Navigation Links
Bionovo to Host Conference Call to Discuss 2011 Highlights and Year-End Financial Results
Date:2/16/2012

EMERYVILLE, Calif., Feb.16, 2012 /PRNewswire/ -- Bionovo, Inc. (OTC Link Platform: BNVI.PK) a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, announced today that it will host a conference call on Tuesday, February 21, 2012 at 1:30 PM PST to discuss its 2011 financial highlights for the year ended December 31, 2011.

(Logo:  http://photos.prnewswire.com/prnh/20111110/SF04662LOGO)

Interested parties can access the call by dialing 877-941-8416, or listen via a live audio only webcast, which can be found at http://bionovo.com/investors/events.  A replay of the call will be available by dialing 1-877-870-5176 (replay code: 4515311) through February 28, 2012 and archived via audio webcast at http://bionovo.com/investors/events.

About Bionovo, Inc.

Bionovo, Inc. is a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, markets with significant unmet needs and billions in potential annual revenue. The company applies its expertise in the biology of menopause and cancer to design new drugs derived from botanical sources, which have novel mechanisms of action. Based on the results of early and mid-stage clinical trials, Bionovo believes it has discovered new classes of drug candidates within its rich pipeline with the potential to be leaders in their markets. Bionovo is headquartered in Emeryville, California and its stock is traded on the OTC Link Platform under the symbol "BNVI.PK." For more information about Bionovo and its programs, visit http://www.bionovo.com.

 

 


'/>"/>
SOURCE Bionovo, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Bionovo Announces Third Quarter 2011 Highlights and Financial Results
2. Bionovo Initiates Menerba (MF101) Phase 3 Clinical Trial for Menopausal Hot Flashes
3. Bionovo to Present Tissue Selective Estrogen Receptor Modulators for Obesity at the 22nd Annual Meeting of the North American Menopause Society
4. Bionovo Announces an Additional 180 Day Period to Regain Compliance With Nasdaqs Bid Price Rule
5. CORRECTED: Bionovo Announces Second Quarter 2011 Highlights and Financial Results
6. Bionovo Announces Second Quarter 2011 Highlights and Financial Results
7. Bionovo to Present the Clinical Promise of Menerba (MF101) for Postmenopausal Vasomotor Symptoms at World Congress on Menopause
8. Bionovo to Announce First Quarter Financial Results on Wednesday, May 11, 2011
9. Bionovo Announces Enrollment Started in the Menerba (MF101) Phase 1 "Tolerability" Clinical Trial for Menopausal Hot Flushes
10. Bionovo Announces 2010 Highlights and Year-End Financial Results
11. Bionovo, Inc. to Announce Fourth Quarter Fiscal Year 2010 Financial Results on Tuesday, March 15, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... 28, 2015  Perrigo Company plc ("Perrigo") (NYSE: ... the acquisition of leading OTC brands from GSK in ... transaction is a clear demonstration of Perrigo,s unique ability ... distribution network spanning 36 countries.  Perrigo ... commented, "We are excited to complete this transaction, which ...
(Date:8/28/2015)... LONDRES, 28 de agosto de 2015   ... su participación en el  Congreso de la ESC ... más recientes y novedosas, entre ellas HeartModel A.I. ... las personas y la tecnología con los protocolos ... guiar los tratamientos y permitir atención en el ...
(Date:8/27/2015)... 27, 2015 DURECT Corporation (Nasdaq: DRRX ... at three upcoming healthcare conferences.  , ... present at the Rodman & Renshaw Investment Conference on ... conference is being held at the St. Regis Hotel ... live audio webcast of the presentation will be available ...
Breaking Medicine Technology:Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 2Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 3Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 5DURECT to Participate in Upcoming Healthcare Conferences 2
... 2011 The Consumer Healthcare Products Association (CHPA) ... North Carolina legislature passing a real-time, stop-sale system ... effective medicines containing pseudoephedrine (PSE), while stopping sales ... passage of a real-time, stop-sale system is a ...
... 2011 SmallCapVoice.com, Inc. announced today that ... Medical Equipment, Inc. (Pinksheets: SHOM), a holding ... durable medical equipment to medical institutions, is ... at http://smallcapvoice.com/blog/6-14-11-audio-interview-with-southern-home-medical-equipment-inc-pink-sheets-shom . SmallCapVoice ...
Cached Medicine Technology:A New Audio Interview With Jerry Overcash, Director for Southern Home Medical Equipment, Inc., is now at SmallCapVoice.com 2A New Audio Interview With Jerry Overcash, Director for Southern Home Medical Equipment, Inc., is now at SmallCapVoice.com 3
(Date:8/31/2015)... ... August 31, 2015 , ... healthbeautydistributors.com has been in ... test marketing a doctor note service to be made available to all patients ... for each generated excuse, much less than the average daily pay of workers. ...
(Date:8/30/2015)... ... August 31, 2015 , ... Avid collector Andrew Hawley from Vintage Rock Posters ... posters. This hand colored artwork is one of the most coveted Doors concert posters. ... "When the doors played the Shrine, the band was one of the biggest ...
(Date:8/30/2015)... ... 2015 , ... ChopChop Kids, the nonprofit publisher of the ... two new officers to serve on the organization’s Board of Directors in accordance ... kids to cook real food with their families and help continue to drive ...
(Date:8/30/2015)... ... ... Scientists in France say asbestos exposure may put workers at higher risk ... just posted an article on the new research. Click here to read it ... 2,024 French asbestos plant workers from 1978 to 2009. In addition to mesothelioma, the ...
(Date:8/30/2015)... Boca Raton, Fl (PRWEB) , ... August 30, ... ... today that Kathleen Kall has been promoted from Administrative assistant to Executive Assistant ... communication, you’ll interact with a proven professional, focused on your goals. Kathleen ...
Breaking Medicine News(10 mins):Health News:ChopChop Kids Appoints New Chair and Vice-Chair to Board of Directors 2Health News:ChopChop Kids Appoints New Chair and Vice-Chair to Board of Directors 3Health News:Researchers Say Mesothelioma Not the Only Cancer Linked with Asbestos Exposure, According to Surviving Mesothelioma 2Health News:NPI Appoints New Executive Assistant To CEO 2
... releases new study of Medigap market, WASHINGTON, ... (Medigap) challenges previous,assumptions about Medigap,s impact on Medicare ... (AHIP) was published this week in the,journal Health ... the Medigap,market which found that Medigap enrollment has ...
... Diabetes and,hypertension are the two leading risk factors ... two-thirds of cases. Yet a new study that ... Clinical Meeting next,month indicates there is wide discrepancy ... these conditions, with patients with high blood,pressure (hypertension) ...
... East Bay Healthcare Executive, OAKLAND, Calif., March 12 ... D. Siljestrom to lead,one of the nation,s largest non-profit ... CEO of East Bay Integrated Care and,executive vice president ... Hill, Calif., begins her new position on April 14, ...
... food, more fruits and vegetables , , WEDNESDAY, March 12 ... instilled healthy eating habits in children aged 2 to ... researchers at the University of Miami Miller School of ... went to eight subsidized child-care centers in Miami Dade ...
... following,is being issued by Foundation for Taxpayer and Consumer ... out against proposed legislation that,would create a loophole in ... without a patient,s consent. The bill, SB 1096,(Calderon), does ... be,necessary to provide health care services. Transfers of private ...
... Pa., March 12 Four,Rivers Software Systems, a ... the healthcare industry and ECRI Institute,an independent nonprofit ... announce the availability of new, real-time interfaces for,their ... This new integration offers hospitals new ...
Cached Medicine News:Health News:New AHIP Study in Health Affairs Challenges Previous Assumptions About Medigap's Impact on Medicare Costs 2Health News:New AHIP Study in Health Affairs Challenges Previous Assumptions About Medigap's Impact on Medicare Costs 3Health News:Large Disparities in Kidney Testing Based on Disease, Gender and State, Quest Diagnostics Health Trends(TM) Report Finds 2Health News:Large Disparities in Kidney Testing Based on Disease, Gender and State, Quest Diagnostics Health Trends(TM) Report Finds 3Health News:Large Disparities in Kidney Testing Based on Disease, Gender and State, Quest Diagnostics Health Trends(TM) Report Finds 4Health News:Large Disparities in Kidney Testing Based on Disease, Gender and State, Quest Diagnostics Health Trends(TM) Report Finds 5Health News:Large Disparities in Kidney Testing Based on Disease, Gender and State, Quest Diagnostics Health Trends(TM) Report Finds 6Health News:Large Disparities in Kidney Testing Based on Disease, Gender and State, Quest Diagnostics Health Trends(TM) Report Finds 7Health News:Transplant Network Appoints Cynthia Siljestrom CEO 2Health News:Preschool Intervention Curbed Trend Toward Obesity 2Health News:Preschool Intervention Curbed Trend Toward Obesity 3Health News:Four Rivers Software Systems and ECRI Institute Announce New, Real-Time Interfaces to Improve Inventory Management and Patient Safety Alert and Recall Tracking 2Health News:Four Rivers Software Systems and ECRI Institute Announce New, Real-Time Interfaces to Improve Inventory Management and Patient Safety Alert and Recall Tracking 3
Immuno-turbidimetric Assay for Antithrombin III Antigen. Suspension of microlatex particles coated with specific antibodies....
Immuno-turbidimetric assay for Free Protein Sby STA© Analyzers. Suspension of microparticles coated with monoclonal antibodies to Free Protein S....
Substrate Plasma for Factor II Assay by STA© Analyzers. Freeze-dried human serum and absorbed bovine plasma, the latter providing factor V and fibrinogen to the test system....
Substrate Plasma for Factor VIII Assay by STA© Analyzers. Freeze-dried human plasma from which factor VIII has been removed by selective immuno-adsorption....
Medicine Products: